Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tyco downsizing

This article was originally published in The Gray Sheet

Executive Summary

Diversified firm's plan to exit over 50 unidentified business units generating $2.1 bil. in sales - including at least some parts of Tyco Healthcare - will save an estimated $230 mil. by 2005, firm predicts. The restructuring program includes consolidating 219 non-healthcare facilities and cutting 7,200 employees, resulting in fiscal 2004 charges of approximately $400 mil. Fiscal fourth quarter 2003 (ended Sept. 30) results announced Nov. 4 included roughly flat revenues of $9.5 bil. and healthcare sales of $2.2 bil. (up 4.6%). The firm foreshadowed the paring of non-core businesses with the divestiture of its Surgical Dynamics spinal unit in June 2002 (1"The Gray Sheet" June 10, 2002, p. 3)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT019315

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel